Abstract
Pain is among the most common symptoms in patients with pancreatic cancer and up to 80% require analgesics, most often as opioids. Unfortunately the analgesic effect is frequently insufficient, and increasing doses are required, resulting in unpleasant side effects. Endoscopic ultrasound-guided neurolysis is a well established method to alleviate or reduce pain due to pancreatic cancer with a documented effect in 80% of patients. The aim of this review is to draw attention to endoscopic ultrasound-guided neurolysis and to discuss its potential which may not be fully utilized.
Bidragets oversatte titel | Endoscopic ultrasound-guided coeliac plexus neurolysis to reduce pain in patients with pancreatic cancer. |
---|---|
Originalsprog | Dansk |
Artikelnummer | V07140404 |
Tidsskrift | Ugeskrift for Laeger |
Vol/bind | 176 |
Sider (fra-til) | 2-5 |
Antal sider | 4 |
ISSN | 0041-5782 |
Status | Udgivet - 2014 |